Erode Cancer Centre Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 1.70 M
as on 20-12-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.66 Cr
as on 20-12-2024
- Satisfied Charges ₹ 1.08 Cr
as on 20-12-2024
- Revenue -11.11%
(FY 2023)
- Profit -18.80%
(FY 2023)
- Ebitda 11.13%
(FY 2023)
- Net Worth -3.46%
(FY 2023)
- Total Assets -8.05%
(FY 2023)
About Erode Cancer Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.70 M.
The company currently has active open charges totaling ₹7.66 Cr. The company has closed loans amounting to ₹1.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kandhappan Velavan and Ponmalar serve as directors at the Company.
- CIN/LLPIN
U85110TZ2005PTC012000
- Company No.
012000
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Erode, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Erode Cancer Centre Private Limited offer?
Erode Cancer Centre Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Erode Cancer Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kandhappan Velavan  | Managing Director | 18-Jul-2005 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ponmalar | Director | 18-Jul-2005 | Current |
Financial Performance of Erode Cancer Centre.
Erode Cancer Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.11% decrease. The company also saw a substantial fall in profitability, with a 18.8% decrease in profit. The company's net worth dipped by a decrease of 3.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Erode Cancer Centre?
In 2023, Erode Cancer Centre had a public holding of 11.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Velmalar Holdings Private LimitedActive 3 years 2 monthsKandhappan Velavan and Ponmalar are mutual person
- Bangalore Cancer Centre Private LimitedActive 15 years 5 months
Kandhappan Velavan and Ponmalar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 23 Nov 2020 | ₹2.80 M | Open |
Others Creation Date: 05 Jul 2017 | ₹6.33 Cr | Open |
Others Creation Date: 08 Feb 2017 | ₹1.05 Cr | Open |
How Many Employees Work at Erode Cancer Centre?
Unlock and access historical data on people associated with Erode Cancer Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Erode Cancer Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erode Cancer Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
